Express Healthcare
Home  »  Uncategorized  »  NEC utilises digital technologies to create healthcare and life science business

NEC utilises digital technologies to create healthcare and life science business

0 61
Read Article

Aiming for business value of 500 billion yen in 2030

NEC Corporation has announced an initiative to create healthcare and life science business that utilises AI and other digital technologies as part of the “creation of future growth businesses” set forth in the 2025 mid-term management plan. NEC will focus on the three areas of medical care, lifestyle support, and life science, aiming for a business value of 500 billion yen (approximately 4.5 billion USD) in 2030.

Specifically, NEC will expand business in the following three areas by taking advantage of its biometrics’ technologies, “Bio-Idiom”, as well as its portfolio of artificial intelligence technologies, “NEC the WISE”, including video analytics and graph-based relationship learning developed by NEC laboratories.

The first area is the “Medical Care” business, featuring digital support for medical care; the second is “Lifestyle Support” business, which helps individuals in their daily lives; and the third is “Life Science” business, which supports personalized medical care with technology. Through these three areas of business, NEC aims to create a world in which individuals may live more freely and comfortably.

In addition, NEC will promote R&D with an eye toward 2030 and the needs of hospitals, nursing care, rehabilitation, and other situations. NEC will also launch the Healthcare and Life Sciences Project Management Office (PMO) to support the acceleration of business development across the NEC Group.

Furthermore, NEC will create new value in the healthcare and life sciences fields through co-creation with a wide range of external partners. In November, for example, NEC will launch NEC Expert Committee on Healthcare and Life Sciences, aiming to implement a future image of society with experts from a variety of positions and perspectives.

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More
The Radiology Conclave : Embrace the new normal
Register Now